Mallinckrodt News and Resources

Mallinckrodt plc and Endo, Inc. have entered into a definitive merger agreement, aiming to form a global pharmaceutical leader with a scaled and diversified portfolio. The transaction, valued at $6.7 billion, will be a stock and cash deal, with Mallinckrodt continuing as the